Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cellular Reprogramming

Cellular Reprogramming
2015 FOUNDED
PRIVATE STATUS
Description

Provider of out footprint-free iPSC derivations on human fibroblasts on a fee-for-service basis. The company has produced hundreds of patient-specific iPSC lines for customers in pharma and academia. The company's iPSC derivation pipeline is based on an advanced form of mRNA reprogramming that affords the fastest, most efficient and safest method of converting human fibroblasts into pluripotent stem cells so far devised.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • 6191 Cornerstone Court East
  • Suite 108
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cellular Reprogramming’s full profile, request a free trial.

Cellular Reprogramming Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellular Dynamics International Formerly VC-backed Madison, WI 000 00000 000000&0 00000
000000 00000000000 Venture Capital-Backed San Diego, CA 00 0000 0000000000 0000
000000000 Formerly VC-backed Yokohama, Japan 000 000.00 00000000 000.00
0000 000000000000 Corporation San Diego, CA 0
00 00000000000 Formerly PE-Backed Shanghai, China 000000000000
To view this company’s complete list of competitors, request access »

Cellular Reprogramming Executive Team (1)

Name Title Board
Seat
Contact
Info
Luigi Warren Ph.D Founder, President, Chief Executive Officer & Chief Financial Officer